These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1859470)

  • 1. Selective 3-hydroxylation deficiency of lidocaine and its metabolite in Dark Agouti rats.
    Masubuchi Y; Umeda S; Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1991 Jul; 42(3):693-5. PubMed ID: 1859470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes.
    Oda Y; Imaoka S; Nakahira Y; Asada A; Fujimori M; Fujita S; Funae Y
    Biochem Pharmacol; 1989 Dec; 38(24):4439-44. PubMed ID: 2604746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
    FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of bunitrolol 4-hydroxylase activity in liver microsomes of dark agouti rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S
    Biochem Pharmacol; 1991 Nov; 42(11):2241-4. PubMed ID: 1958240
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
    Barham HM; Lennard MS; Tucker GT
    Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.
    Wang JS; Backman JT; Taavitsainen P; Neuvonen PJ; Kivistö KT
    Drug Metab Dispos; 2000 Aug; 28(8):959-65. PubMed ID: 10901707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of propranolol and irreversible binding to rat liver microsomes: strain differences and effects of inhibitors.
    Masubuchi Y; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1992 Feb; 43(3):635-7. PubMed ID: 1540217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
    Masubuchi Y; Araki J; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism.
    Larrey D; Distlerath LM; Dannan GA; Wilkinson GR; Guengerich FP
    Biochemistry; 1984 Jun; 23(12):2787-95. PubMed ID: 6432035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two P-450 isozymes placed in the rat CYP2D subfamily.
    Ohishi N; Imaoka S; Suzuki T; Funae Y
    Biochim Biophys Acta; 1993 Nov; 1158(3):227-36. PubMed ID: 8251521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
    Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
    Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of lidocaine by rat pulmonary cytochrome P450.
    Tanaka K; Oda Y; Asada A; Fujimori M; Funae Y
    Biochem Pharmacol; 1994 Mar; 47(6):1061-6. PubMed ID: 8147905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.
    Bargetzi MJ; Aoyama T; Gonzalez FJ; Meyer UA
    Clin Pharmacol Ther; 1989 Nov; 46(5):521-7. PubMed ID: 2582709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of lidocaine in human liver in vitro.
    Hermansson J; Glaumann H; Karlén B; von Bahr C
    Acta Pharmacol Toxicol (Copenh); 1980 Jul; 47(1):49-52. PubMed ID: 7395524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
    Veronese ME; McManus ME; Laupattarakasem P; Miners JO; Birkett DJ
    Drug Metab Dispos; 1990; 18(3):356-61. PubMed ID: 1974199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
    Masubuchi Y; Takahashii C; Fujio N; Horie T; Suzuki T; Imaoka S; Funae Y; Narimatsu S
    Drug Metab Dispos; 1995 Sep; 23(9):999-1003. PubMed ID: 8565792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
    Ellis SW; Ching MS; Watson PF; Henderson CJ; Simula AP; Lennard MS; Tucker GT; Woods HF
    Biochem Pharmacol; 1992 Aug; 44(4):617-20. PubMed ID: 1510710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
    Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursor-metabolite interaction in the metabolism of lidocaine.
    Suzuki T; Fujita S; Kawai R
    J Pharm Sci; 1984 Jan; 73(1):136-8. PubMed ID: 6694073
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of CYP2D6 in oxidative metabolism of cinnarizine and flunarizine in human liver microsomes.
    Narimatsu S; Kariya S; Isozaki S; Ohmori S; Kitada M; Hosokawa S; Masubuchi Y; Suzuki T
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1262-8. PubMed ID: 8323546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.